Chemical composition and antibacterial activity of bee venom against multi-drug resistant pathogens.

Bee venom with an antimicrobial effect is a powerful natural product. One of the most important areas where new antimicrobials are needed is in the prevention and control of multi-drug resistant pathogens. Today, antibacterial products used to treat multi-drug resistant pathogen infections in hospitals and healthcare facilities are insufficient to prevent colonisation and spread, and new products are needed. The aim of the study is to investigate the antibacterial effect of the bee venom (BV), a natural substance, on the species of Methicillin resistant Staphylococcus aureus, Vancomycin resistant Enterococcus faecalis, Carbapenem resistant Escherichia coli, Carbapenem resistant Klebsiella pneumoniae and Carbapenem resistant Acinetobacter baumannii. As a result of this study, it was found that MIC90 and MBC90 values ranged from 6.25 µg/mL - 12.5 µg/mL and numbers of bacteria decreased by 4-6 logs within 1-24 h for multi-drug resistant pathogens. In particular, Vancomycin resistant Enterococcus faecalis isolate decreased 6 log cfu/mL at 50 µg/mL and 100 µg/mL concentrations in the first hour. The effective bacterial inhibition rate of bee venom suggests that it could be a potential antibacterial agent for multi-drug resistant pathogens.Contribution: The treatment options of antibiotic-resistant pathogens are a major problem in both veterinary and human medicine fields. We have detected a high antibacterial effect against these agents in this bee venom study, which is a natural product. Apitherapy is a fashionable treatment method all over the world and is used in many areas of health. Bee venom is also a product that can be used as a drug or disinfectant raw material and can fill the natural product gap that can be used against resistant bacteria.

Estimating the total economic costs of Neospora caninum infections in dairy cows in Turkey.

The aim of this study was to estimate the total cost of Neospora caninum infection in cows in Turkey. According to present literature, the mean seroprevalence of infection was estimated as 14.7%. The seropositivity rate of N. caninum in aborted cows was found to be 18%. The financial costs were estimated in US$ at 2019 prices. The total cost of N. caninum infection was estimated at US$710 (438-1043) per a dairy cow and the annual economic costs were estimated at US$40.5 (24.6-60.3) million for Turkey. In this study, the distribution of economic costs caused by neosporosis per cow was determined to be 67.3% for abortion, 16.8% prolonged calving interval, 4.6% milk loss, 3.5% additional artificial insemination, and 7.7% veterinary and diagnostic costs, respectively. All studies that have been conducted so far on Neosporosis are focused on the prevalence and the diagnosis of the disease in Turkey. In this study, we firstly determined the economic costs due to N. caninum infections and try to attract attention on the economic impacts of the disease. As a result, awareness among breeders regarding the epidemiology, control, and eradication of neosporosis should be raised through training activities; coordination between the relevant institutions and organizations should be ensured; emergency action plans should be prepared; and further spread of the disease should be prevented.